Liver Stellate Cells and Aminoterminal Peptide of Type III Procollagen in Chronic Hepatitis C Treated with Interferon

Hepato-Gastroenterology

Volumn 50, Issue 54, 2003, Pages 2017-2021

  Gabrielli, Giovanni B ^a,b   Casaril, Massimo ^a   Stanzial, Anna Maria ^a   Colombari, Romano ^a   Pasino, Michela ^a   Corrocher, Roberto ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Medicina Interna B   (Italy)

Author keywords

Chronic hepatitis C; Interferon; Ito cells; Liver stellate cells; Myofibroblasts; Procollagen

Indexed keywords

ALPHA ACTIN; INTERFERON; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FIBROGENESIS; FOLLOW UP; HEPATITIS C; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER BIOPSY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RELAPSE; SCORING SYSTEM; STELLATE CELL;

ACTINS; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOPSY; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROCOLLAGEN; TREATMENT OUTCOME;

EID: 0344961337     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Torres-Salinas M, Parès A, Caballerìa J, et al: Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology 1986; 90:1241-1246.
2. Van Zanten RA, van Leeuwen RE, Beukers R, et al: Procollagen III peptide levels in alcoholic liver disease and primary biliary cirrhosis. Neth J Med 1988; 32:278-284.
3. Gressner AM: Measurement of connective tissue parameters in serum for diagnosis and follow-up of liver fibrosis. Ann Clin Biochem 1987; 24:283-292.
4. Gabrielli GB, Corrocher R: Hepatic fibrosis and its serum markers: a review. Dig Dis 1991; 9:303-316.
5. Serejo F, Costa A, Oliveira AG, et al: α-Interferon improves liver fibrosis in chronic hepatitis C. Clinical significance of the serum N-terminal propeptide of procollagen type III. Dig Dis Sci 2001; 46:1684-1689.
6. Capra F, Casaril M, Gabrielli GB, et al: α-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J. Hepatol 1993; 18:112-118.
7. Milani S, Herbst H, Schuppan D, et al: Cellular localization of type I, II and IV procollagen gene transcripts in normal and fibrotic human liver. Am J Pathol 1990; 137:59-70.
8. Gressner AM: Cytokines and cellular crosstalk involved in the activation of fat storing cells. J Hepatol 1995; 22(Suppl 2):28-36.
9. Hellebrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA: The role of TGFb1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999; 30:77-87.
10. Friedman SL: Hepatic stellate cells. Prog Liver Dis 1996; 14:101-130.
11. Yamaoka K, Toshihiko N, Marumo F, Sato C: Alpha smooth muscle actin expression in normal and fibrotic human liver. Dig Dis Sci 1993; 8:1473-1479.
12. Guido M, Rugge M, Chemello L, et al: Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. J Hepatol 1996; 24:301-307.
13. Sakaida I, Nagatomi A, Hironaka K, Uchida K, Okita K: Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Am J Gastroenterol 1999; 94:489-496.
14. Khan MA, Poulos JE, Brunt EM, et al: Hepatic α-smooth muscle actin expression in hepatitis C patients before and after Interferon therapy. Hepatogastroenterology 2001; 48:212-215.
15. Capra F, De Maria E, Lunardi C, et al: Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: a prognostic marker for responses to interferon treatment. J Infect Dis 2000; 181:425-431.
16. International Group: Acute and chronic hepatitis revisited. Lancet 1977; ii:914-919.
17. Scheur PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13:372-374
18. Gabrielli GB, Capra F, Casaril M, et al: Serum laminin and type III procollagen in chronic hepatitis C: Diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta 1997; 265:21-31.
19. Schmitt-Graeff A, Krueger S, Bochard F, Gabbiani G, Denk H: Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991; 138:1233-1242.
20. Geerts A, Vrijsen R, Rauterberg J, et al: In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 1989; 9:59-68.
21. Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F: Appearance of α-smooth muscle actin positive cells in hepatic fibrosis. Liver 1991; 11:100-105.
22. De Leeuw AM, McCarthy SP, Geerts A, Knook DL: Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 1984; 4:392-403.
23. Hironaka K, Sakaida I, Uchida K, Okita K: Correlation between stellate cell activation and serum fibrosis markers in choline-deficient L-amino acid-defined diet-induced rat liver fibrosis. Digest Dis Sci 2000; 45:1935-1943.